AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

 

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Research > Animal Research

AAMC's Comment Letter to USDA on the Definition of "Animal" in the Animal Welfare Act Regulations

[On January 28, 1999, the Animal and Plant Health Inspection Service issued a Federal Register notice (64 FR 4356) seeking comments on a "Petition for Rulemaking" regarding the definition of "animal" in the regulations implementing Animal Welfare Act. The AAMC response is provided below. AAMC sent a letter to USDA Secretary Glickman on September 8, 2000 on this same topic.]

May 28, 1999

Regulatory Analysis and Development Program
Planning and Development
Animal and Plant Health Inspection Service (APHIS)
U.S. Department of Agriculture
Suite 3C03
4700 River Road, Unit 118
Riverdale, MD 20737-1238

RE: Docket No. 98-106-1

Dear Sir:

The Association of American Medical Colleges (AAMC) appreciates having the opportunity to comment on the petition currently before the Department requesting that the definition of "animal" in the Animal Welfare Act (AWA) regulations be amended to include rats and mice bred for research, as well as birds.

The AAMC represents the nation's 125 accredited medical schools, nearly 400 major teaching hospitals, more than 87,000 faculty in 87 professional and scientific societies, and the nation's 67,000 medical students and 102,000 residents. More than half of the extramural research funding awarded by the National Institutes of Health goes to medical schools and their affiliated teaching hospitals. Much of this research involves the use of rats and mice. As such, the Association has a long history of involvement in legislative and regulatory issues concerning the use of animals in research.

The Association has reviewed the comment letter of the National Association for Biomedical Research (NABR) and heartily endorses the NABR position. The AAMC and many of its constituent institutions are members of NABR and contributed to its analysis of the petition under consideration. We particularly urge the Department to review NABR's discussion of the legislative history behind the definition of "animal" in the Animal Welfare Act as well as its analysis of the related legal issues.

The AAMC has a strong commitment to the humane care and treatment of laboratory animals. For ethical, scientific and financial reasons, AAMC member institutions recognize their responsibility to develop and maintain the highest standards of laboratory animal care and treatment. Most AAMC member institutions are accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). Participation in the voluntary accreditation program of AAALAC demonstrates that these research institutions are not only meeting the minimums required by law, but are going the extra step to achieve and showcase excellence in animal care and use.

Questions Posed in APHIS' Notice of Petition and Request for Comment

1. Should the definition of "animal" in 9 CFR Part 1 be revised to include laboratory rats, laboratory mice, and birds, or any of the three?

The Association has no philosophical objection to including research rats, mice and birds in the AWA regulatory definition of "animal." However, there are profound implementation issues related to such an action that make us apprehensive about the wisdom of such a decision. All of our institutions are currently subject to the standards embodied in the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and the Institute for Laboratory Animal Research Guide. Our institutions believe the humane care and use of research animals is necessary for scientific as well as ethical reasons. Reliable research results can only be obtained if researchers, institutional officials and veterinarians are attentive to laboratory animal well-being.

Should APHIS proceed to include rats, mice and birds under the AWA regulatory regime, a number of implementation issues must be carefully considered:

  • The regulation of the species must be done in a manner that is fully consistent with the standards embodied in the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals and the Institute for Laboratory Animal Research Guide. Such regulations should be based on performance standards and not engineering standards.
  • The regulatory and paperwork burden on institutions and researchers must be minimized. Every dollar spent on needless and inefficient recordkeeping is a dollar that cannot be used for research on potentially life-saving research.
  • APHIS must be given the financial and other resources to perform properly the major additional responsibilities that would necessarily derive from such a redefinition. New obligations must not be permitted to compromise existing animal welfare enforcement activities.

2. If the definition of "animal" in 9 CFR Part 1 is amended to include laboratory rats, laboratory mice, and birds, should [the Office of] Animal Care regulate the care provided to these species in all circumstances covered by the AWA or in certain circumstances, such as use in research, only?

Regulations must be based on a demonstrated need and not based on expediency. Although initially regulating rats, mice and birds at currently USDA-registered research facilities may be the expedient approach, these institutions may be the last ones that need additional oversight. Similarly, suggestions that APHIS perform abbreviated or modified inspections of rats, mice and birds are equally troubling. Inspection authority is an important feature of the USDA's animal welfare responsibilities. As NABR noted, "Since there are already federal and private animal welfare standards for rats, mice and birds used in research, if USDA does not intend to conduct inspections, it is exceedingly difficult to understand why the Department would choose to create redundant federal regulations." Any new regulations must be consistent with existing enforcement efforts and have a fair and logical rationale in terms of the need to adopt them. A patchwork system of regulation makes compliance difficult and enforcement nearly impossible.

3. The AWA requires that USDA inspect all research facilities at least once a year. Because of current and anticipated resources for AWA enforcement, any coverage of rats, mice and birds would result in significantly reduced numbers of inspections for other AWA-regulated entities, such as dog and cat dealers, intermediate handlers and carriers, large and small zoos, and circuses. Should AWA enforcement activities be equal for all species covered by the AWA? If not, what should be the relative priorities?

In our view, it is unacceptable to reduce further the number of inspections conducted at currently registered or licensed entities. All species and regulated entities covered by AWA regulations should be treated equally. APHIS should be provided with sufficient resources to accomplish this objective.

4. If the definition of "animal" in 9 CRR Part 1 is amended to include laboratory rats, laboratory mice, and birds, how many additional facilities would come under USDA regulation?

We do not possess any data that would assist in estimating the number of new facilities that would be subject to USDA regulation should rats, mice and birds be included in the AWA regulations. However, countless high schools and community colleges use rats and mice in non-invasive behavioral research and hundreds of biotechnology firms use only transgenic mice in their research activities. A broadened definition of "animal" would subject these firms and institutions to USDA regulation for the first time. We understand that NABR has gathered data that may provide USDA with more quantitative information on this issue. We appreciate the opportunity to comment on this issue. Please feel free to contact the Association if we can provide additional comments as you consider the petition.

Sincerely,

Jordan J. Cohen, M.D.
President, AAMC

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement